3
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Helicobacter pylori Infection and Inflammation

Pages 23-30 | Published online: 08 Jul 2009

References

  • Warren J R, Marshall B J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273–1275
  • Wyatt J I, Rathbone B J, Heatley R V. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol 1987; 39: 863–870
  • Shousha S, Bull T B, Parkins R A. Gastric spiral bacteria. Lancet 1984; 2: 101
  • Morris A, Nicholson G. Campylobacter pylori: human ingestion studies. Campylobacter pylori and gastroduodenal disease, B J Rathbone, R V Heatley. Blackwell Scientific Publications, Oxford 1989; 185
  • Marshall B, Armstrong J, McGechie D, Glancy R. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 152: 436–439
  • Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192–199
  • Crabtree J E, Sobala G M, Taylor J D, Dixon M F, Heatley R V. Acute gastritis: a case study of the mucosal humoral response to Helicobacter pylori. Rev Esp Enf Digest 1990; 76, Suppl I
  • Dixon M F. Campylobacter pylori and chronic gastritis. Campylobacter pylori and gastroduodenal disease, B J Rathbone, R V Heatley. Blackwell Scientific Publications, Oxford 1989; 106
  • Bayerdörffer E, Oertel H, Lehn N. Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol 1989; 42: 834–839
  • Stolte M, Eidt S, Ohnsmann A. Differences in Helicobacter pylori-associated gastritis in the antrum and body of the stomach. Z Gastroenterol 1990; 28: 229–233
  • Steininger H, Schneider U, Bartz K, Simmler B. Campylobacter pylori und Gastritis—Besiedelungsdichte und Grad der Entzündung. Semiquantitative und morphometrische Untersuchung. Leber Magen Darm 1989; 19: 70–78
  • Collins J SA, Sloan J M, Hamilton P W, Watt P CH, Love A HG. Investigation of the relationship between gastric antral inflammation and Campylobacter pylori using graphic tablet planimetry. J Pathol 1989; 159: 281–285
  • Chen X G, Correa P, Offerhaus J. Ultra-structure of the gastric mucosa harbouring Campylobacter-like organisms. Am J Clin Pathol 1986; 86: 575–582
  • Tricottet V, Bruneval P, Vire O, Camilleri J P. Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol 1986; 10: 113–122
  • Kazi J L, Sinniah R, Zaman V. Ultrastructural study of Helicobacter pylori-associated gastritis. J Pathol 1990; 161: 65–70
  • Hessey S J, Wyatt J I, Axon A TR, Sobala G, Rathbone B J, Dixon M F. The relationship between adhesion sites and disease activity in C. pylori-associated gastritis. Gut 1990; 31: 134–138
  • Steer H W. Surface morphology of the gastroduodenal mucosa in duodenal ulceration. Gut 1984; 25: 1203–1210
  • Johnson B J, Reed P I, Ali M H. Campylobacter-like organisms in duodenal and antral endoscopic biopsies: Relationship to inflammation. Gut 1986; 27: 1132–1137
  • Wyatt J I, Rathbone B J, Dixon M F, Heatley R V. Campylobacter pyloridis and acid-induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987; 40: 841–848
  • Caselli M, Bovolenta M R, Aleotti A. Epithelial morphology of duodenal bulb and Campylobacter-like organisms. J Submicrosc Cytol 1988; 20: 237–242
  • Bode G, Malfertheiner P, Ditschuneit H. Pathogenetic implications of ultrastructural findings in Campylobacter pylori-related gastroduodenal disease. Scand J Gastroenterol 1987; 23(Suppl 142)25–39
  • Wyatt J I, Rathbone B J, Sobala B M. Gastric epithelium in the duodenum: Its association with Helicobacter pylori and inflammation. J Clin Pathol 1990; 43: 981–986
  • Toukan A U, Kamali M F, Amr S S, Arnaout M A, Abu-Romiyeh A S. Gastroduodenal inflammation in patients with non-ulcer dyspepsia. A controlled endoscopic and morphometric study. Dig Dis Sci 1985; 30: 313–320
  • Greenlaw R, Sheahan D G, DeLuca V, Miller D, Myerson D, Myerson P. Gastroduodenitis, a broader concept of peptic ulcer disease. Dig Dis Sci 1980; 25: 660–672
  • Thomson W O, Joffe S N, Robertson A G, Lee F D, Imrie C W, Blumgart L H. Is duodenitis a dyspeptic myth?. Lancet 1977; 1: 1197–1198
  • Collins J SA, Hamilton P W, Watt P CH, Sloan J M, Love A HG. Quantitative histological study of mucosal inflammatory cell densities in endoscopic duodenal biopsy specimens from dyspeptic patients using computer linked image analysis. Gut 1990; 31: 858–861
  • Jonsson K A, Gotthard R, Bodemar G, Brodin U. The clinical relevance of endoscopic and histologic inflammation of gastroduodenal mucosa in dyspepsia of unknown origin. Scand J Gastroenterol 1989; 24: 385–395
  • Shallcross T M, Rathbone B J, Heatley R V. Campylobacter pylori and non-ulcer dyspepsia. Campylobacter pylori and gastroduodenal disease, B J Rathbone, R V Heatley. Blackwell Scientific Publications, Oxford 1989; 155
  • Marshall B J, Hislop I, Glancy R, Armstrong J. Histological improvement of active gastritis in patients treated with De-Nol. Aust NZ J Med 1984; 14(Suppl 4)907
  • McNulty C AM, Gearty J C, Crump. Campylobacter pyloridis and associated gastritis; investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J 1986; 293: 645–649
  • Rauws E AJ, Langenberg W, Houthoff H F, Zanen H C, Tytgat G NJ. Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 1988; 94: 33–40
  • Rokkas T, Pursey C, Simmons N A, Filipe M I, Sladen G E. Non-ulcer dyspepsia and colloidal bismuth subcitrate therapy: the role of Campylobacter pyloridis. Gastroenterology 1987; 92: 1599
  • Borody T, Hennesey W, Daskalopoulos G, Garrick J, Hazell S. Double-blind trial of De-Nol in non-ulcer dyspepsia associated with Campylobacter pyloridis gastritis. Gastroenterology 1987; 92: 1324
  • Lambert J R, Borromeo M, Korman M G, Hansky J. Role of Campylobacter pyloridis in non-ulcer dyspepsia. A randomised controlled trial. Gastroenterology 1987; 91: 1488
  • Rauws E AJ, Tytgat G N. Campylobacter pylori: treatment of gastritis. Campylobacter pylori and gastroduodenal disease, B J Rathbone, R V Heatley. Blackwell Scientific Publications, Oxford 1989; 225
  • Rathbone B J, Wyatt J I, Worsley B W. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut 1986; 27: 642–647
  • Rathbone B J, Wyatt J I, Tompkins D, Heatley R V, Losowsky M S. In vitro production of Campylobacter pyloridis specific antibodies by gastric mucosal biopsies. Gut 1986; 27: A607
  • Wyatt J I, Rathbone B J. Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 1988; 23(Suppl 142)44–49
  • Crabtree J E, Rathbone B J, Shallcross T M, Heatley R V, Losowsky M S. Duodenal secretion of Campylobacter pylori specific antibodies in patients with gastritis and duodenitis. Gut 1988; 29: A1438
  • Pruul H, Lee P C, Goodwin C S. Interaction of Campylobacter pyloridis with human immune defence mechanisms. J Med Microbiol 1987; 23: 233–238
  • Papadimitriou C S, Ioachim-Velogianni E E, Tsianos E B. Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis. Virchows Arch [Pathol Anat] 1988; 413: 197–204
  • Rathbone B J, Wyatt J I, Trejdosiewicz L K. Mucosal T cell subsets in normal gastric antrum and C. pylori-associated chronic gastritis. Gut 1988; 29: A1438
  • Engstrand L, Scheynius A, Pahlson C. Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun 1989; 57: 827–832
  • Crabtree J E, Shallcross T M, Wyatt J I, Heatley R V. Tumour necrosis factor alpha secretion by Helicobacter pylori colonised gastric mucosa. Gut 1990; 31: A600
  • Shallcross T M, Rathbone B J, Wyatt J I, Heatley R V. Helicobacter pylori-associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 1990; 4: 515–522
  • Shallcross T M, Wyatt J I, Rathbone B J, Heatley R V. Non-steroidal anti-inflammatory drugs, hiatus hernia and Helicobacter pylori in patients with oesophageal ulceration. Br J Rheumatol 1990; 29: 288–290

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.